257 related articles for article (PubMed ID: 12566361)
21. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction.
Tamura K; Nakajima H; Rakue H; Sasame A; Naito Y; Nagai Y; Ibukiyama C
Jpn Circ J; 1999 May; 63(5):357-61. PubMed ID: 10943614
[TBL] [Abstract][Full Text] [Related]
22. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
Brunner B; Gunsilius E; Schumacher P; Zwierzina H; Gastl G; Stauder R
J Hematother Stem Cell Res; 2002 Feb; 11(1):119-25. PubMed ID: 11847008
[TBL] [Abstract][Full Text] [Related]
23. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
Batchelor WB; Tolleson TR; Huang Y; Larsen RL; Mantell RM; Dillard P; Davidian M; Zhang D; Cantor WJ; Sketch MH; Ohman EM; Zidar JP; Gretler D; DiBattiste PM; Tcheng JE; Califf RM; Harrington RA
Circulation; 2002 Sep; 106(12):1470-6. PubMed ID: 12234950
[TBL] [Abstract][Full Text] [Related]
24. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Ugurel S; Rappl G; Tilgen W; Reinhold U
J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
[TBL] [Abstract][Full Text] [Related]
25. Increased angiogenic growth factor in cyanotic congenital heart disease.
Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
[TBL] [Abstract][Full Text] [Related]
26. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
[TBL] [Abstract][Full Text] [Related]
27. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
[TBL] [Abstract][Full Text] [Related]
28. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
[TBL] [Abstract][Full Text] [Related]
29. Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics.
Aref S; Mabed M; Sakrana M; Goda T; El-Sherbiny M
Hematology; 2002 Oct; 7(5):273-9. PubMed ID: 12850814
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Aguayo A; Kantarjian H; Manshouri T; Gidel C; Estey E; Thomas D; Koller C; Estrov Z; O'Brien S; Keating M; Freireich E; Albitar M
Blood; 2000 Sep; 96(6):2240-5. PubMed ID: 10979972
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients.
Salven P; Orpana A; Teerenhovi L; Joensuu H
Blood; 2000 Dec; 96(12):3712-8. PubMed ID: 11090051
[TBL] [Abstract][Full Text] [Related]
33. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
[TBL] [Abstract][Full Text] [Related]
35. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
Boersma E; Akkerhuis KM; Théroux P; Califf RM; Topol EJ; Simoons ML
Circulation; 1999 Nov; 100(20):2045-8. PubMed ID: 10562258
[TBL] [Abstract][Full Text] [Related]
36. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.
Kleiman NS; Lincoff AM; Kereiakes DJ; Miller DP; Aguirre FV; Anderson KM; Weisman HF; Califf RM; Topol EJ
Circulation; 1998 May; 97(19):1912-20. PubMed ID: 9609084
[TBL] [Abstract][Full Text] [Related]
38. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
[TBL] [Abstract][Full Text] [Related]
39. Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma.
Berglund A; Molin D; Larsson A; Einarsson R; Glimelius B
Ann Oncol; 2002 Sep; 13(9):1430-7. PubMed ID: 12196369
[TBL] [Abstract][Full Text] [Related]
40. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
